Sulabha Ranganathan

Sulabha Ranganathan is a highly experienced clinical scientist with a diverse background in clinical research and development within the biopharmaceutical industry. Currently serving as a Contract Clinical Scientist at Iovance Biotherapeutics, Inc. since November 2024, Ranganathan has previously held significant leadership roles such as Executive Director of Clinical Research at Shattuck Labs and Executive Director, Clinical Scientist at Incyte. Ranganathan's extensive career includes key positions at Adaptimmune, Novartis Pharmaceuticals, GlaxoSmithKline, Wyeth, and Fox Chase Cancer Center, culminating in over three decades of expertise in oncology clinical and operational sciences. Ranganathan holds a PhD in Biology with a focus on Toxicology and Teratology, complemented by a Master of Science in Biosciences from Andhra University.